[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "",
    "text": "Study Objective: Examine the impact of household income and insurance status on stroke management and outcomes among inpatient admissions with atrial fibrillation.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of Stroke.\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nStroke\nCardiogenic Shock\nCardiac Arrest\nUtilization of Percutaneous Coronary Intervention\nUtilization of Coronary Artery Bypass Grafting\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, cancer, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, fluid/electrolyte imbalance, obesity, prior stroke, prior cardiac surgery, presence of pacemaker/defibrillator.\nComorbidities: Charlson comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "",
    "text": "Study Objective: Examine the impact of household income and insurance status on stroke management and outcomes among inpatient admissions with atrial fibrillation.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of Stroke.\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nStroke\nCardiogenic Shock\nCardiac Arrest\nUtilization of Percutaneous Coronary Intervention\nUtilization of Coronary Artery Bypass Grafting\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, cancer, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, fluid/electrolyte imbalance, obesity, prior stroke, prior cardiac surgery, presence of pacemaker/defibrillator.\nComorbidities: Charlson comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 8,0651\nAMI without IBD\nN = 8,0151\nAMI with IBD\nN = 501\np-value2\n\n\n\n\nAge, y\n66 (14)\n66 (14)\n76 (11)\n0.004\n\n\nSex\n\n\n\n\n\n\n0.11\n\n\n    Female\n2,885 (36%)\n2,855 (36%)\n30 (60%)\n\n\n\n\n    Male\n5,180 (64%)\n5,160 (64%)\n20 (40%)\n\n\n\n\nRace\n\n\n\n\n\n\n0.8\n\n\n    White\n5,660 (71%)\n5,620 (71%)\n40 (80%)\n\n\n\n\n    Asian or Pacific Islander\n200 (2.5%)\n200 (2.5%)\n0 (0%)\n\n\n\n\n    Black\n880 (11%)\n870 (11%)\n10 (20%)\n\n\n\n\n    Hispanic\n810 (10%)\n810 (10%)\n0 (0%)\n\n\n\n\n    Native American\n60 (0.8%)\n60 (0.8%)\n0 (0%)\n\n\n\n\n    Other\n325 (4.1%)\n325 (4.1%)\n0 (0%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n0.076\n\n\n    $1 - $51,999\n2,545 (32%)\n2,545 (32%)\n0 (0%)\n\n\n\n\n    $52,000 - $65,999\n2,305 (29%)\n2,295 (29%)\n10 (22%)\n\n\n\n\n    $66,000 - $87,999\n1,720 (22%)\n1,700 (22%)\n20 (44%)\n\n\n\n\n    $88,000 or more\n1,315 (17%)\n1,300 (17%)\n15 (33%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n0.2\n\n\n    Private\n1,930 (24%)\n1,930 (24%)\n0 (0%)\n\n\n\n\n    Medicaid\n925 (11%)\n925 (12%)\n0 (0%)\n\n\n\n\n    Medicare\n4,395 (55%)\n4,350 (54%)\n45 (90%)\n\n\n\n\n    Other\n800 (9.9%)\n795 (9.9%)\n5 (10%)\n\n\n\n\nLevel of urbanization\n\n\n\n\n\n\n0.059\n\n\n    Central metro ≥1 million\n2,335 (29%)\n2,330 (29%)\n5 (10%)\n\n\n\n\n    Fringe metro ≥1 million\n1,630 (20%)\n1,630 (20%)\n0 (0%)\n\n\n\n\n    Metro 250,000-999,999\n1,670 (21%)\n1,635 (20%)\n35 (70%)\n\n\n\n\n    Metro 50,000-249,999\n795 (9.9%)\n790 (9.9%)\n5 (10%)\n\n\n\n\n    Micropolitan\n1,005 (12%)\n1,000 (13%)\n5 (10%)\n\n\n\n\n    Other\n605 (7.5%)\n605 (7.6%)\n0 (0%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n0.011\n\n\n    Midwest\n1,440 (18%)\n1,415 (18%)\n25 (50%)\n\n\n\n\n    Northeast\n1,225 (15%)\n1,210 (15%)\n15 (30%)\n\n\n\n\n    South\n3,510 (44%)\n3,505 (44%)\n5 (10%)\n\n\n\n\n    West\n1,890 (23%)\n1,885 (24%)\n5 (10%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n0.2\n\n\n    Large\n3,715 (46%)\n3,690 (46%)\n25 (50%)\n\n\n\n\n    Medium\n2,630 (33%)\n2,625 (33%)\n5 (10%)\n\n\n\n\n    Small\n1,720 (21%)\n1,700 (21%)\n20 (40%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n0.8\n\n\n    Rural\n760 (9.4%)\n755 (9.4%)\n5 (10%)\n\n\n\n\n    Urban, non-teaching\n1,515 (19%)\n1,510 (19%)\n5 (10%)\n\n\n\n\n    Urban, teaching\n5,790 (72%)\n5,750 (72%)\n40 (80%)\n\n\n\n\nCharlson comorbidity index\n3.14 (1.95)\n3.13 (1.95)\n3.60 (1.71)\n0.2\n\n\nHypertension\n6,535 (81%)\n6,500 (81%)\n35 (70%)\n0.4\n\n\nChronic kidney disease\n1,895 (23%)\n1,875 (23%)\n20 (40%)\n0.2\n\n\nObesity\n1,805 (22%)\n1,800 (22%)\n5 (10%)\n0.3\n\n\nDiabetes Mellitus\n3,365 (42%)\n3,345 (42%)\n20 (40%)\n&gt;0.9\n\n\nChronic pulmonary disease\n1,705 (21%)\n1,700 (21%)\n5 (10%)\n0.4\n\n\nLiver Disease\n345 (4.3%)\n335 (4.2%)\n10 (20%)\n0.015\n\n\nPeripheral vascular disease\n955 (12%)\n955 (12%)\n0 (0%)\n0.2\n\n\nHyperlipidemia\n5,350 (66%)\n5,310 (66%)\n40 (80%)\n0.4\n\n\nCongestive heart failure\n3,430 (43%)\n3,415 (43%)\n15 (30%)\n0.4\n\n\nCancer\n205 (2.5%)\n200 (2.5%)\n5 (10%)\n0.13\n\n\nObstructive sleep apnea\n635 (7.9%)\n635 (7.9%)\n0 (0%)\n0.3\n\n\nArrhythmia\n2,930 (36%)\n2,920 (36%)\n10 (20%)\n0.3\n\n\nValvular heart disease\n1,155 (14%)\n1,150 (14%)\n5 (10%)\n0.7\n\n\nSmoker\n1,755 (22%)\n1,750 (22%)\n5 (10%)\n0.4\n\n\nPrior stroke\n810 (10%)\n805 (10%)\n5 (10%)\n&gt;0.9\n\n\nPrior PCI\n1,490 (18%)\n1,485 (19%)\n5 (10%)\n0.5\n\n\nPrior CABG\n785 (9.7%)\n780 (9.7%)\n5 (10%)\n&gt;0.9\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nAMI without IBD\nN = 8,0151\nAMI with IBD\nN = 501\np-value2\n\n\n\n\nIn-hospital mortality\n380 (4.7%)\n0 (0%)\n0.5\n\n\nLength of stay (days)\n3.0 (2.0, 5.0)\n4.0 (2.0, 7.0)\n0.3\n\n\nAdjusted total charges\n75,670 (42,066, 126,630)\n52,652 (31,666, 106,937)\n0.3\n\n\nCardiogenic shock\n580 (7.2%)\n0 (0%)\n0.4\n\n\nStroke\n240 (3.0%)\n5 (10%)\n0.2\n\n\nCardiac arrest\n240 (3.0%)\n0 (0%)\n0.6\n\n\nPercutaneous coronary intervention\n4,155 (52%)\n20 (40%)\n0.5\n\n\nCoronary artery bypass grafting\n595 (7.4%)\n0 (0%)\n0.4\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nAge, y\n1.02\n0.99, 1.05\n0.13\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.59\n0.36, 0.97\n0.036\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.91\n0.59, 6.19\n0.3\n\n\n    Black\n1.73\n0.71, 4.21\n0.2\n\n\n    Hispanic\n1.30\n0.54, 3.15\n0.6\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n1.23\n0.43, 3.58\n0.7\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.90\n0.95, 3.79\n0.068\n\n\n    $66,000 - $87,999\n1.89\n0.81, 4.42\n0.14\n\n\n    $88,000 or more\n2.55\n1.09, 5.98\n0.031\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.76\n0.19, 3.05\n0.7\n\n\n    Medicare\n2.22\n0.94, 5.25\n0.069\n\n\n    Other\n3.21\n1.20, 8.56\n0.020\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.77\n0.36, 1.67\n0.5\n\n\n    Metro 250,000-999,999\n0.98\n0.45, 2.14\n&gt;0.9\n\n\n    Metro 50,000-249,999\n1.80\n0.70, 4.61\n0.2\n\n\n    Micropolitan\n1.14\n0.39, 3.33\n0.8\n\n\n    Other\n2.05\n0.69, 6.09\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.34\n0.48, 3.77\n0.6\n\n\n    South\n1.58\n0.66, 3.79\n0.3\n\n\n    West\n2.00\n0.85, 4.72\n0.11\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.95\n0.56, 1.63\n0.9\n\n\n    Small\n0.39\n0.16, 0.94\n0.037\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.00\n0.33, 3.02\n&gt;0.9\n\n\n    Urban, teaching\n0.80\n0.27, 2.38\n0.7\n\n\nCharlson comorbidity index\n0.99\n0.71, 1.37\n&gt;0.9\n\n\nHypertension\n0.83\n0.41, 1.69\n0.6\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.28\n0.43, 3.82\n0.7\n\n\nObesity\n0.66\n0.28, 1.55\n0.3\n\n\nDiabetes Mellitus\n1.52\n0.77, 3.00\n0.2\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.51, 2.06\n&gt;0.9\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.91\n1.25, 6.78\n0.014\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.20, 1.40\n0.2\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.52\n0.30, 0.89\n0.018\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.08\n1.08, 4.03\n0.029\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n0.35, 4.48\n0.7\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.15\n0.02, 1.31\n0.086\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.94\n1.61, 5.38\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.12\n0.56, 2.21\n0.8\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.47, 2.17\n&gt;0.9\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.32, 1.85\n0.6\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.39, 1.79\n0.7\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.28, 1.92\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiogenic Shock:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nAge, y\n1.00\n0.98, 1.03\n0.8\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.01\n0.65, 1.58\n&gt;0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.58\n0.51, 4.95\n0.4\n\n\n    Black\n0.91\n0.40, 2.09\n0.8\n\n\n    Hispanic\n0.91\n0.37, 2.27\n0.8\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n1.70\n0.71, 4.03\n0.2\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.54\n0.89, 2.65\n0.12\n\n\n    $66,000 - $87,999\n1.44\n0.76, 2.74\n0.3\n\n\n    $88,000 or more\n1.93\n0.97, 3.83\n0.062\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.06\n0.51, 2.22\n0.9\n\n\n    Medicare\n1.26\n0.60, 2.65\n0.5\n\n\n    Other\n1.63\n0.72, 3.69\n0.2\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.70\n0.38, 1.30\n0.3\n\n\n    Metro 250,000-999,999\n0.93\n0.50, 1.74\n0.8\n\n\n    Metro 50,000-249,999\n1.13\n0.50, 2.55\n0.8\n\n\n    Micropolitan\n1.19\n0.49, 2.89\n0.7\n\n\n    Other\n0.88\n0.33, 2.37\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.69\n0.29, 1.64\n0.4\n\n\n    South\n1.70\n0.87, 3.33\n0.12\n\n\n    West\n1.16\n0.55, 2.45\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.98\n0.59, 1.62\n&gt;0.9\n\n\n    Small\n0.54\n0.28, 1.05\n0.069\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.43\n0.40, 5.05\n0.6\n\n\n    Urban, teaching\n3.16\n0.95, 10.5\n0.060\n\n\nCharlson comorbidity index\n0.82\n0.59, 1.15\n0.2\n\n\nHypertension\n0.73\n0.44, 1.23\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n0.46, 3.49\n0.6\n\n\nObesity\n0.70\n0.38, 1.32\n0.3\n\n\nDiabetes Mellitus\n1.54\n0.78, 3.07\n0.2\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.35, 1.49\n0.4\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.66\n2.78, 11.6\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.49\n0.78, 2.86\n0.2\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.44, 1.06\n0.091\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4.64\n2.56, 8.41\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.15, 3.19\n0.6\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.22\n0.05, 1.00\n0.051\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.82\n1.78, 4.49\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.51\n0.89, 2.56\n0.12\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.56, 1.72\n&gt;0.9\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.38, 1.88\n0.7\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.38\n0.18, 0.82\n0.014\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.41, 1.84\n0.7\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiac Arrest:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nAge, y\n1.00\n0.96, 1.03\n&gt;0.9\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.35\n0.67, 2.72\n0.4\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.98\n0.42, 9.22\n0.4\n\n\n    Black\n3.21\n1.23, 8.39\n0.017\n\n\n    Hispanic\n1.03\n0.25, 4.22\n&gt;0.9\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n0.67\n0.08, 5.43\n0.7\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n2.34\n0.94, 5.86\n0.069\n\n\n    $66,000 - $87,999\n2.13\n0.67, 6.78\n0.2\n\n\n    $88,000 or more\n3.30\n1.04, 10.5\n0.044\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.41\n0.08, 2.04\n0.3\n\n\n    Medicare\n2.23\n0.91, 5.48\n0.080\n\n\n    Other\n1.15\n0.36, 3.70\n0.8\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n1.35\n0.56, 3.21\n0.5\n\n\n    Metro 250,000-999,999\n1.40\n0.52, 3.80\n0.5\n\n\n    Metro 50,000-249,999\n0.86\n0.22, 3.35\n0.8\n\n\n    Micropolitan\n0.82\n0.17, 3.99\n0.8\n\n\n    Other\n0.92\n0.17, 5.00\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.96\n0.32, 2.87\n&gt;0.9\n\n\n    South\n1.37\n0.56, 3.35\n0.5\n\n\n    West\n1.42\n0.56, 3.60\n0.5\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.88\n0.43, 1.80\n0.7\n\n\n    Small\n0.80\n0.33, 1.97\n0.6\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.24\n0.22, 7.02\n0.8\n\n\n    Urban, teaching\n1.08\n0.21, 5.63\n&gt;0.9\n\n\nCharlson comorbidity index\n1.18\n0.89, 1.55\n0.2\n\n\nHypertension\n0.63\n0.27, 1.45\n0.3\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.27, 2.25\n0.6\n\n\nObesity\n2.42\n1.07, 5.50\n0.035\n\n\nDiabetes Mellitus\n1.16\n0.50, 2.71\n0.7\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.28, 1.72\n0.4\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.34\n0.82, 6.63\n0.11\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.51\n0.15, 1.76\n0.3\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.20, 0.84\n0.015\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.35, 1.94\n0.7\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.18\n0.02, 1.60\n0.12\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8.22\n3.62, 18.7\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.29, 1.97\n0.6\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.32, 2.12\n0.7\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.36, 2.96\n&gt;0.9\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.34, 1.91\n0.6\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.37, 2.95\n&gt;0.9\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nStroke:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n9.76\n1.50, 63.4\n0.017\n\n\nAge, y\n1.01\n0.97, 1.04\n0.7\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.39\n0.60, 3.21\n0.4\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.07\n0.00, 301\n0.5\n\n\n    Black\n1.22\n0.38, 3.95\n0.7\n\n\n    Hispanic\n0.51\n0.18, 1.45\n0.2\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n13.1\n3.81, 44.8\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.44\n0.51, 4.08\n0.5\n\n\n    $66,000 - $87,999\n1.07\n0.32, 3.58\n&gt;0.9\n\n\n    $88,000 or more\n0.81\n0.21, 3.06\n0.8\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.65\n0.16, 2.60\n0.5\n\n\n    Medicare\n0.55\n0.16, 1.83\n0.3\n\n\n    Other\n1.22\n0.25, 5.98\n0.8\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.70\n0.20, 2.46\n0.6\n\n\n    Metro 250,000-999,999\n1.33\n0.36, 4.91\n0.7\n\n\n    Metro 50,000-249,999\n0.98\n0.20, 4.95\n&gt;0.9\n\n\n    Micropolitan\n0.66\n0.16, 2.76\n0.6\n\n\n    Other\n0.96\n0.15, 6.29\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.83\n0.12, 5.78\n0.8\n\n\n    South\n1.78\n0.52, 6.03\n0.4\n\n\n    West\n4.94\n1.56, 15.7\n0.007\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.65\n0.25, 1.66\n0.4\n\n\n    Small\n1.15\n0.42, 3.20\n0.8\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.12\n0.01, 1.06\n0.057\n\n\n    Urban, teaching\n0.84\n0.12, 5.61\n0.9\n\n\nCharlson comorbidity index\n2.82\n2.14, 3.73\n&lt;0.001\n\n\nHypertension\n0.67\n0.20, 2.28\n0.5\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.08\n0.02, 0.29\n&lt;0.001\n\n\nObesity\n0.89\n0.24, 3.29\n0.9\n\n\nDiabetes Mellitus\n0.30\n0.12, 0.78\n0.014\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.24\n0.07, 0.76\n0.015\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n0.46, 3.86\n0.6\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n0.46, 2.78\n0.8\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.37, 2.14\n0.8\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.23, 2.21\n0.6\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.04, 3.57\n0.4\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.50\n1.13, 10.8\n0.030\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n0.61, 3.30\n0.4\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n0.51, 3.51\n0.6\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.16, 1.82\n0.3\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n40.9\n18.2, 91.6\n&lt;0.001\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.49\n0.54, 4.12\n0.4\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.52\n0.15, 1.82\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Characteristics and Outcomes of Patients with Inflammatory Bowel Disease and Acute Myocardial Infarction",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n0.38\n-1.2, 2.0\n0.6\n\n\nAge, y\n0.00\n-0.02, 0.03\n0.8\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n-0.04\n-0.49, 0.41\n0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.9\n-0.05, 3.8\n0.056\n\n\n    Black\n0.49\n-0.31, 1.3\n0.2\n\n\n    Hispanic\n-0.28\n-0.90, 0.35\n0.4\n\n\n    Native American\n0.26\n-1.8, 2.3\n0.8\n\n\n    Other\n1.1\n-0.52, 2.8\n0.2\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.33\n-0.19, 0.85\n0.2\n\n\n    $66,000 - $87,999\n0.12\n-0.50, 0.75\n0.7\n\n\n    $88,000 or more\n0.17\n-0.64, 0.99\n0.7\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.07\n-0.52, 0.66\n0.8\n\n\n    Medicare\n0.43\n-0.22, 1.1\n0.2\n\n\n    Other\n0.50\n-0.23, 1.2\n0.2\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n-0.19\n-0.83, 0.45\n0.6\n\n\n    Metro 250,000-999,999\n-0.24\n-0.89, 0.40\n0.5\n\n\n    Metro 50,000-249,999\n0.36\n-0.53, 1.3\n0.4\n\n\n    Micropolitan\n0.50\n-0.47, 1.5\n0.3\n\n\n    Other\n-0.25\n-1.1, 0.56\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.25\n-0.51, 1.0\n0.5\n\n\n    South\n0.45\n-0.15, 1.1\n0.14\n\n\n    West\n-0.40\n-1.0, 0.22\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.24\n-0.76, 0.28\n0.4\n\n\n    Small\n-0.94\n-1.5, -0.37\n0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.70\n-0.09, 1.5\n0.084\n\n\n    Urban, teaching\n1.9\n1.1, 2.7\n&lt;0.001\n\n\nCharlson comorbidity index\n0.62\n0.22, 1.0\n0.002\n\n\nHypertension\n0.03\n-0.51, 0.57\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.28\n-1.3, 0.76\n0.6\n\n\nObesity\n0.26\n-0.27, 0.79\n0.3\n\n\nDiabetes Mellitus\n-0.60\n-1.4, 0.21\n0.14\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.41\n-1.2, 0.35\n0.3\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n-0.81, 2.4\n0.3\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.08\n-0.94, 0.78\n0.9\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.10\n-0.56, 0.36\n0.7\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.18, 1.4\n0.011\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.91\n-2.6, 0.81\n0.3\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.18\n-0.66, 1.0\n0.7\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.5\n0.99, 2.0\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.3\n0.59, 1.9\n&lt;0.001\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.09\n-0.55, 0.37\n0.7\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.56\n-1.2, 0.09\n0.089\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.78\n-1.3, -0.26\n0.004\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.95\n-1.5, -0.40\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nIBD\n\n\n\n\n\n\n\n\n    AMI without IBD\n—\n—\n\n\n\n\n    AMI with IBD\n-14,961\n-41,689, 11,768\n0.3\n\n\nAge, y\n-490\n-1,187, 206\n0.2\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n15,486\n3,539, 27,433\n0.011\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n23,928\n-22,197, 70,054\n0.3\n\n\n    Black\n-443\n-18,754, 17,868\n&gt;0.9\n\n\n    Hispanic\n-4,718\n-21,264, 11,828\n0.6\n\n\n    Native American\n-710\n-61,478, 60,058\n&gt;0.9\n\n\n    Other\n45,464\n-5,513, 96,440\n0.080\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n2,052\n-12,965, 17,069\n0.8\n\n\n    $66,000 - $87,999\n5,016\n-12,352, 22,384\n0.6\n\n\n    $88,000 or more\n6,191\n-18,153, 30,534\n0.6\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-1,072\n-18,672, 16,528\n&gt;0.9\n\n\n    Medicare\n9,272\n-7,292, 25,836\n0.3\n\n\n    Other\n19,593\n-6,812, 45,998\n0.15\n\n\nLevel of urbanization\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n-3,545\n-23,309, 16,219\n0.7\n\n\n    Metro 250,000-999,999\n819\n-24,416, 26,054\n&gt;0.9\n\n\n    Metro 50,000-249,999\n-4,222\n-27,299, 18,855\n0.7\n\n\n    Micropolitan\n-4,773\n-24,897, 15,351\n0.6\n\n\n    Other\n-17,355\n-43,432, 8,721\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n9,418\n-8,831, 27,666\n0.3\n\n\n    South\n34,230\n19,455, 49,006\n&lt;0.001\n\n\n    West\n37,989\n19,900, 56,078\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-10,749\n-27,713, 6,215\n0.2\n\n\n    Small\n-21,126\n-36,854, -5,397\n0.009\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n16,331\n-3,012, 35,674\n0.10\n\n\n    Urban, teaching\n41,638\n22,639, 60,638\n&lt;0.001\n\n\nCharlson comorbidity index\n12,452\n1,417, 23,487\n0.027\n\n\nHypertension\n3,411\n-8,694, 15,516\n0.6\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-23,245\n-44,998, -1,492\n0.036\n\n\nObesity\n-945\n-15,155, 13,264\n0.9\n\n\nDiabetes Mellitus\n-11,926\n-36,507, 12,655\n0.3\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,368\n-23,755, 15,020\n0.7\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n12,208\n-24,657, 49,072\n0.5\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-18,938\n-39,741, 1,865\n0.074\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n7,517\n-4,082, 19,116\n0.2\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8,594\n-5,749, 22,938\n0.2\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-37,731\n-71,285, -4,177\n0.028\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,585\n-23,612, 16,443\n0.7\n\n\nArrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n31,654\n19,492, 43,817\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n10,260\n-6,747, 27,266\n0.2\n\n\nSmoker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,277\n-19,731, 5,177\n0.3\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-29,241\n-43,235, -15,248\n&lt;0.001\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,153\n-25,073, 768\n0.065\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-32,118\n-45,512, -18,724\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]